Selective serotonin reuptake inhibitors in pregnancy and lactation

Obstetrical and Gynecological Survey

Volumn 53, Issue 12, 1998, Pages 733-736

  Gupta, Sanjay ^a   Masand, Prakash S ^b   Rangwani, Sunil ^b  

^a Olean General Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; NORFLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BREAST FEEDING; BREAST MILK; CLINICAL TRIAL; CONGENITAL MALFORMATION; DEPRESSION; DRUG EXCRETION; DRUG SAFETY; FEMALE; HUMAN; LACTATION; PREGNANCY; REVIEW; SPONTANEOUS ABORTION;

ANIMALS; BREAST FEEDING; DEPRESSION; DEPRESSION, POSTPARTUM; FEMALE; FLUOXETINE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032428193     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199812000-00002     Document Type: Review

References (17)

1. Kuller JA, Katz VL, McMahon MJ et al. Pharmacologic treatment of psychiatric disease in pregnancy and lactation: Fetal and neonatal effects. Obstet Gynecol 1996;87:789-794.
2. Altshuler LL, Cohen L, Szuba MP et al. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. Am J Psychiatry 1996;153:592-606.
3. Pastuszak A, Schick-Boschetto B, Zuber C et al. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac). JAMA 1993;269:2246-2248.
4. Chambers CD, Johnson KA, Dick LM et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335: 1010-1015.
5. Nulman I, Rovet J, Steward DE et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-262.
6. Chambers CD, Johnson KA, Jones KL. Pregnancy outcome in women exposed to fluoxetine. Teratology 1993;47:386.
7. Goldstein DJ, Corbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet. Gynecol 1997; 89:713-718.
8. Briggs GG, Freeman RK, Yaffee SJ, eds. Drugs in Pregnancy and Lactation. 4th ed. Baltimore: Williams & Wilkins, 1994.
9. Goldstein DJ, Marvel DE. Psychotropic medications during pregnancy: Risk to the fetus. J Am Med Assoc 1993;270:2177.
10. Goldstein DJ. Effects of third trimester fluoxetine exposure on newborn. J Clin Psychopharmacol 1995;15:417-420.
11. Stowe ZN, Llewellyn AM, Strader JR et al. Placental passage of antidepressants. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, May 1997.
12. Physicians' Desk Reference, 50th ed. Montvale, NJ: Medical Economics, 1998:2229-2232, 2851-2856, 2891-2894.
13. Lester BM, Cucca J, Andreozzi L et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32:1253-1255.
14. Kim J, Misri S, Riggs KW et al. Stereoselective excretion of fluoxetine and norfluoxetine in breast milk and neonatal exposure. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, May 1997.
15. DeVane CL. Pharmacokinetics of selective serotonin reuptake inhibitors. J Clin Psychiatry 1992;53:13-20.
16. Llewellyn AM, Stove ZN, Nemcroff CB. Infant outcome after sertraline exposure. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, May 1997.
17. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996;153:1132-1137.